Search results
27 maj 2024 · In children who had not been vaccinated against COVID-19 prior to infection, there was an increased risk of hospital admission with MIS-C following a SARS-CoV-2 positive test (IRR 11.52, 95%CI...
18 kwi 2023 · In this systematic review on safety and effectiveness of EMA-approved COVID-19 vaccines in children aged 5–11-years, we found that a primary vaccination series with the mRNA-based vaccines (BNT162b2 and mRNA-1273) showed a high efficacy against SARS-CoV-2 infections and symptomatic COVID-19 in pivotal studies, which were done during a pre ...
Among children and adolescents, the safety of current COVID‐19 vaccines is acceptable, and studies have suggested that mRNA vaccines can provide high protection against COVID‐19 infection in pediatric age groups.
9 lis 2021 · This study describes immunization against SARS-CoV-2 infection with an mRNA vaccine in children younger than 12 years of age and documents the safety, immunogenicity, and efficacy of a...
Interpretation: In children aged 5-11 years, mRNA vaccines are moderately effective against infections with the omicron variant, but probably protect well against COVID-19 hospitalisations. Vaccines were reactogenic but probably safe.
15 lut 2023 · Safe and effective vaccines against coronavirus disease 2019 (Covid-19) are urgently needed in young children. Methods. We conducted a phase 1 dose-finding study and are conducting an...
24 lut 2022 · Patients with severe COVID-19 receive highly concentrated oxygen so that inflamed but ventilated alveoli are exposed to hyperoxia, which could worsen the oxidative stress and trigger endothelial dysfunction.
